# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001485003-23-000089
Filing Date
2023-02-28
Accepted
2023-02-28 08:00:53
Documents
22
Period of Report
2023-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | sesn-20230228.htm iXBRL | 8-K | 38069
2 | EX-99.1 | a20230228_4q2022earnings.htm | EX-99.1 | 28229
6 |  | a20230228_4q2022earnings001.jpg | GRAPHIC | 229752
7 |  | a20230228_4q2022earnings002.jpg | GRAPHIC | 283209
8 |  | a20230228_4q2022earnings003.jpg | GRAPHIC | 303470
9 |  | a20230228_4q2022earnings004.jpg | GRAPHIC | 291179
10 |  | a20230228_4q2022earnings005.jpg | GRAPHIC | 338612
11 |  | a20230228_4q2022earnings006.jpg | GRAPHIC | 308454
12 |  | a20230228_4q2022earnings007.jpg | GRAPHIC | 127167
13 |  | a20230228_4q2022earnings008.jpg | GRAPHIC | 125047
14 |  | a20230228_4q2022earnings009.jpg | GRAPHIC | 110487
| Complete submission text file | 0001485003-23-000089.txt |  | 3126931

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sesn-20230228.xsd | EX-101.SCH | 1902
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sesn-20230228_lab.xml | EX-101.LAB | 24849
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sesn-20230228_pre.xml | EX-101.PRE | 13046
16 | EXTRACTED XBRL INSTANCE DOCUMENT | sesn-20230228_htm.xml | XML | 9595

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 23678461
SIC: 2834 Pharmaceutical Preparations